Cholestyramine manufacturers

Filters

cholestyramine

Sachets 4 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bangladesh , Canada , Chile , Cuba , Cyprus , Denmark , Guatemala , Honduras , Hong Kong , Jordan , Laos , Lebanon , Malaysia , Malta , Mexico , Myanmar , Nicaragua , Pakistan , Serbia , Singapore , Slovenia , Sri Lanka , Sweden , Thailand , United Kingdom , United States , Vietnam , Yemen
Registered in
Argentina , Canada , Chile , Cuba , Cyprus , Denmark , Finland , Guatemala , Honduras , Hungary , Jordan , Malta , Mexico , Netherlands , Nicaragua , Peru , Portugal , Serbia , Saudi Arabia , Singapore , Slovenia , Sweden , Thailand , United Arab Emirates , United States , Vietnam
Available for
Licensing with supply, Distribution only
Comments
Flavour: Orange
Manufacturer #10620

A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, the Middle East, North America, LATAM, and Asia for 50+ years. The main therapeutic areas include cardiovascular, rheumatology, nephrology, and central nervous system. The main dosage forms are oral solid and multi-dose powder. They are produced in GMP-compliant manufacture.

cholestyramine

Powder for oral suspension 4 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #16210
This FDA-registered producer specializes in unit-dose pharmaceutical products, offering a diverse range of oral liquid medications in both cups and pre-filled syringes, alongside tablets and capsules in blister packs. Their experienced management team boasts expertise across various aspects of the pharmaceutical industry, including manufacturing, repackaging, distribution, operations, quality/compliance, and marketing. The company focuses on providing unit-dose solutions for a variety of therapeutic areas, utilizing oral solutions, syrups, suspensions, tablets, and capsules as principal dosage forms.

cholestyramine

Granules for oral suspension 4 gm

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #23786
Founded in the 1950s with nearly seven decades of pharmaceutical leadership, this integrated pharma company is among the top players in its home market. Rx and OTC portfolio spans branded generics, biosimilars, APIs, and novel drugs across oncology, metabolic, cardiac, and infectious disease therapy areas. US FDA and EU-GMP approved facilities operate across multiple continents.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Cholestyramine is a bile acid sequestrant that is primarily used to reduce cholesterol levels in the blood caused by partial bile obstruction. Suppliers most commonly market it in the form of 4g powders for oral suspension. The largest manufacturer supplier of trade name cholestyramine medications is Bristol-Meyers Squib. Although other manufacturing companies also market generic formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 100 sachets of 4mg cholestyramine powder for oral suspension fall into an approximate range of 50.00 EUR to 70.00 EUR.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.